Superior Planning, LLC’s Genmab GMAB Stock Holding History

Superior Planning, LLC’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.57K	Buy	+72	New	+$2.28K	﹤0.01%	1475

Other funds holding GMAB

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Superior Planning, LLC's GMAB Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Genmab (GMAB) in Q3 2026: 72 shares worth $2.57K. The stake represents ﹤0.01% of the portfolio and ranks #1475 among its holdings.

204 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

Superior Planning, LLC held 72 shares of Genmab worth $2.57K as of Q3 2026.
Genmab was a new Superior Planning, LLC position in Q3 2026.
Genmab made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1475 holding.
204 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.